Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 271-280 of 329 for lung cancer

Edit search filters
  1. A Study to Evaluate Maximizing Anti-PD-1 Therapy By Monitoring T Cell Responses In Melanoma, Lung and Other Cancer Types

    Rochester, MN

  2. Preclinical drug testing and assay development for lung adenocarcinoma characterized by the expression of ASCL1

    Rochester, MN

  3. Registry for the EVolution Of LUng Cancer Therapy Implementation and Outcomes Now

    Rochester, MN

  4. Transbronchial Biopsy Assisted by Robot Guidance in the Evaluation of Tumors of the Lung

    Scottsdale/Phoenix, AZ

  5. A Study to Collect Medical and Personal Histories, Blood and/or Tumor Tissue Samples from Patients Who are Long-term Survivors of Lung Cancer

    Rochester, MN

  6. Profiling of Lung Cancer for Identification of Treatment Targets and Strategies

    Jacksonville, FL

  7. A Study to Develop a Decision Aid for Patients Having Lung Screening

    Rochester, MN

  8. Surgical Drain Fluid for Detection of Molecular Residual Disease in Patients With Non-small Cell Lung Cancers

    Rochester, MN

  9. Development of Novel Mutation Detection Methods for Lung Cancer

    Rochester, MN

  10. A Study of Patients Undergoing Neoadjuvant Therapy for Resectable Non-small Cell Lung Cancer to Evaluate Perioperative Circulating Tumor DNA as a Prognostic Biomarker

    Jacksonville, FL

.

Mayo Clinic Footer